The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis
Nicola Farina,Giovanni Benanti,Giacomo De Luca,Anna Palmisano,Giovanni Peretto,Sara Tomassetti,Veronica Giorgione,Ornella Forma,Antonio Esposito,Silvio Danese,Lorenzo Dagna,Marco Matucci-Cerinic,Corrado Campochiaro
DOI: https://doi.org/10.2147/JMDH.S295478
2022-04-20
Journal of Multidisciplinary Healthcare
Abstract:Nicola Farina, 1, 2, &ast Giovanni Benanti, 1, 2, &ast Giacomo De Luca, 1, 2 Anna Palmisano, 2, 3 Giovanni Peretto, 4 Sara Tomassetti, 5 Veronica Giorgione, 6 Ornella Forma, 7 Antonio Esposito, 2, 3 Silvio Danese, 2, 8 Lorenzo Dagna, 1, 2 Marco Matucci-Cerinic, 1, 9 Corrado Campochiaro 1, 2 1 Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy; 2 School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; 3 Unit of Clinical and Experimental Radiology, IRCCS San Raffaele Hospital, Milan, Italy; 4 Unit of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Hospital, Milan, Italy; 5 Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy; 6 Molecular and Clinical Sciences Research Institute, Fetal Medicine Unit, Department of Obstetrics and Gynaecology, St. George's University Hospitals NHS Foundation Trust, London, UK; 7 Vulnology Nursing Service, IRCCS San Raffaele Scientific Institute, Milan, Italy; 8 Unit of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Milan, Italy; 9 Department of Experimental and Clinical Medicine, University of Florence and Division of Rheumatology AOUC, Florence, Italy &astThese authors contributed equally to this work Correspondence: Corrado Campochiaro, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy, Tel +39 0226437060, Fax +39 0226433729, Email Systemic sclerosis (SSc) is a rare connective tissue disease characterised by immune dysfunction, vascular damage and fibrosis affecting the skin and multiple internal organs. The clinical spectrum of SSc is wide and its manifestations may lead to severe morbidity and mortality, in addition to a great impact on patients' quality of life. Due to the multifaceted clinical manifestations of SSc, its management requires a combined expertise of different medical specialists to guarantee an adequate disease control and prevent organ complications. Multi-disciplinary teams (MDT), which are composed by physicians and other specialized health professionals, represent therefore a key element for the comprehensive management of SSc patients. Moreover, MTD can improve communication and patients' empowerment while the presence of dedicated nurses can help patients to ask questions about their condition. The scope of this narrative review is to analyse the available evidences regarding the role of MDT in the management of SSc patients, and how this holistic approach may improve different disease domains and the overall prognosis. MDT regarding the cardiovascular and lung complication are the more represented in literature, given the great impact in prognosis. Nonetheless, MDT have been shown to be fundamental also in other disease domains as they can intercept early manifestations, thus stratifying patients based on the individual risks in order to personalize patients' follow-up. MDTs may also minimize the treatment delay, enabling fast-track specialist referral. On the other hand, there are few trials specifically studying MDT in SSc and several authors have highlight the lack of standardization. Keywords: systemic sclerosis, scleroderma, multidisciplinary team, shared management Systemic sclerosis (SSc) is a rare connective tissue disease characterised by immune dysfunction, vascular damage and fibrosis affecting the skin and multiple internal organs, such as the cardiovascular and respiratory systems. 1 The clinical spectrum of SSc is wide and its manifestations may lead to severe morbidity and mortality, in addition to a great impact on patients' quality of life. 2 In the last decades, the therapeutic algorithm of SSc has broadened to encompass a combination of immunomodulatory and vasodilatative drugs along with non-pharmacological measures, with beneficial effects on survival rates and morbidity. 3,4 Due to the multifaceted clinical manifestations of SSc, its management requires, in addition to rheumatologic care, the combined expertise of different medical specialists to guarantee an adequate disease control and prevent its complications (Figure 1). 3 Multi-disciplinary teams (MDT) are composed of rheumatologists and other specialists and comprise both physicians and other health professionals, such as specialised nurses and physical therapists. MDT's members can effectively deal with several aspects of the disease that impact on SSc patients' progno -Abstract Truncated-
health care sciences & services